Devson Catalyst Limited

Basic Materials — Specialty Chemicals · BSE

₹370.00−₹2.95 (−0.79%)

DalalBaazaar Score

64 / 100

🟢 Good

Verdict

NEUTRAL

Risk

Very High

Driven by high debt relative to equity, negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: Strong business and financial position, with modest growth. Debt is the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:03 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Devson Catalyst Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Devson Catalyst Limited manufactures and sells specialty products used in industrial processes in India and internationally.

IndustrySpecialty Chemicals

SectorBasic Materials

Employees59

Annual revenue₹55 Cr

How does it make money?

Turns over ₹55 Cr a year. Of every ₹100 of sales, about ₹23 reaches shareholders as profit, with ₹32 left at the operating level before interest, tax and depreciation. Each of its 59 employees supports ₹93.6 lakh of revenue a year, the signature of a people-led business.

EBITDA margin31.9%

Net margin22.7%

Revenue / employee₹93.6 lakh

Who are its competitors?

The closest listed comparisons in its industry are ASIAN PAINTS LIMITED, PIDILITE INDUSTRIES LTD, SRF LTD, UPL LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

ASIAN PAINTS LIMITEDP/E 46.9x · ROE 22.3%

PIDILITE INDUSTRIES LTDP/E 57.8x · ROE 24.4%

SRF LTDP/E 33.8x · ROE 15.4%

UPL LIMITEDP/E 21.5x · ROE 6.1%

What is its competitive advantage?The numbers suggest a real one

ROCE has stayed above 15% in every year available and stands at 49.7%. Returns that high normally get competed away; when they persist, something is protecting them, and its ROE of 46.0% against a peer median of 22.3% is consistent with that. What that something is — brand, scale, switching costs, regulation — the accounts cannot tell you.

ROCE49.7%

ROE46.0%

Peer median ROE22.3%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +71% while net margin moved +214% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+71%

Margin effect+214%

DalalBaazaar Score

64/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ High leverage magnifies any downturn in earnings
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

75/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

48/ 100

Fair

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

39.8x

Sector Median

40.4x

median of 4 sector peers

🟡Against its sector it is priced broadly in line with the peer median of 40.4x.

vs. its own history

Not enough price and earnings history

vs. sector peers

Fair

40.4x median of 4 peers · -1%

vs. generic bands

Expensive

Above 35x

P/E (Trailing)

39.8x

P/B

11.32x

EV/EBITDA

28.6x

PEG

0.53

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well5

Margins are improving
EBITDA margin is up from 11.8% to 31.9% over 3 years.
Return on equity is rising
ROE has improved from 25.3% to 37.4%.
Return on capital is rising
ROCE has improved from 36.8% to 49.7%.
High return on capital employed
ROCE of 49.7% is the mark of a business that converts capital into profit efficiently.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention4

Debt is rising
Total debt is up 82% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Receivables growing faster than sales
Receivables are up 231% against revenue growth of 71% — customers are taking longer to pay.
Inventory building faster than sales
Inventory is up 103% against revenue growth of 71% — stock may not be moving.

Red Flags

5 items require attention · 3 high · 2 watch

🔴Debt has risen sharplyFinancial
Total debt is up 82% over 3 years, from ₹1 Cr to ₹3 Cr.
🔴High leverageFinancial
Debt/Equity of 7.47x — earnings must service borrowings before shareholders see anything.
🔴Receivables growing faster than salesFinancial
Receivables up 231% against revenue up 71% — sales are being booked faster than they are collected.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹1 Cr in the latest year.
🟡Inventory building faster than salesFinancial
Inventory up 103% against revenue up 71% — stock may not be moving.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 49.7% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Margin expansion has further to run
EBITDA margin has risen from 11.8% to 31.9%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Leverage amplifies any setback
Debt/Equity of 7.47x. Interest is payable whether or not the business has a good year.
Sales are being booked faster than collected
Receivables are up 231% against revenue up 71%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
3 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 15% a year✓ 19.5% CAGR
Latest reported year was 4.5%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 30%✓ 31.9%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹1 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 0.1x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 47%✓ 49.7%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

9 / 11 checks passed

✓ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

4 good · 4 neutral · 3 weak

Market Cap

₹503 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

39.8x

Fair

Fairly valued against the generic band

P/B Ratio

11.32x

Rich

Steep premium to book — needs high, durable returns to justify

EPS (TTM)

₹9.29

Profitable

Profitable on a per-share basis

ROE

46.0%

Strong

Strong capital efficiency

ROCE

49.7%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

7.47x

High

High leverage

Revenue Growth (YoY)

4.5%

Modest

Modest growth

Profit Growth (YoY)

63.2%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹3 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹370

ROA

29.4%

Good

Assets are working hard

Operating Margin

31.2%

Good

Healthy core-business profitability

Net Margin

22.4%

Good

Strong bottom-line conversion

Current Ratio

4.18

Comfortable

Healthy short-term liquidity

52W Range Position

78%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

353.9 / 312.0

Bullish alignment (short > long)

RSI (14)

62.5

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹32 Cr	₹43 Cr	₹53 Cr	₹55 Cr	+19.5%
EBITDA	₹4 Cr	₹7 Cr	₹11 Cr	₹18 Cr	+66.4%
EBITDA Margin	11.8%	16.4%	21.5%	31.9%	—
PAT (Net Profit)	₹2 Cr	₹4 Cr	₹8 Cr	₹13 Cr	+75.0%
EPS	₹1.72	₹3	₹5.65	₹9.21	+75.0%
ROE	25.3%	30.7%	36.6%	37.4%	—
ROCE	36.8%	47.0%	50.2%	49.7%	—
Total Debt	₹1 Cr	₹4 Cr	₹3 Cr	₹3 Cr	+22.1%
Free Cash Flow	₹1 Cr	-₹2 Cr	₹4 Cr	-₹1 Cr	—

🟢 Revenue has grown at 19.5% a year over 3 years.

🟢 EBITDA has grown at 66.4% a year over 3 years.

🟢 EBITDA Margin has risen from 11.8% to 31.9% over 3 years (+20.1 pts).

🟢 PAT (Net Profit) has grown at 75.0% a year over 3 years.

🟢 EPS has grown at 75.0% a year over 3 years.

🟢 ROE has risen from 25.3% to 37.4% over 3 years (+12.1 pts).

🟢 ROCE has risen from 36.8% to 49.7% over 3 years (+12.8 pts).

🔴 Total Debt has grown at 22.1% a year over 3 years.

🔴 Free Cash Flow has turned negative, from ₹1 Cr to -₹1 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹42 Cr

Total Liabilities

₹8 Cr

Total Debt

₹3 Cr

Cash & Equivalents

₹2 Cr

Operating Cash Flow

₹5 Cr

Capex

-₹5 Cr

Shareholding (proxy)

Institutional Holding

1.3%

Insider Holding

78.3%

Peer Comparison

Company	P/E	ROE
ASIAN PAINTS LIMITED	46.9x	22.3%
PIDILITE INDUSTRIES LTD	57.8x	24.4%
SRF LTD	33.8x	15.4%
UPL LIMITED	21.5x	6.1%

Recent News

6 general

Devson Catalyst Ltd Share Price

Business Today, 16 Oct

Compare INDIA GELAT. with

Equitymaster, 16 Oct

DEVSON CATALYST LIMITED Share Price

Upstox, 09 Oct

Strong listing: Devson Catalyst shares debut with 66% premium over its IPO price on BSE SME

Moneycontrol.com, 16 Jul

Devson Catalyst IPO Allotment Status: Steps to Verify Status & Key Issue Details

Groww, 13 Jul

Devson Catalyst shares to debut today; GMP hints at 42% listing gain

The Economic Times, 16 Jul

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟢Business QualityStrong17.9/20

🟡Financial HealthAdequate9.9/20

🟢GrowthStrong14.9/20

🟢ProfitabilityStrong13.5/15

🔴ValuationDemanding5/15

🔴RiskHigh2.5/10

Good business at a fair price

A sound business at a reasonable valuation. Suitable for a long-term holding, with the valuation and the direction of margins worth watching rather than the business itself. 3 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓Revenue growth stays above 15% a year19.5% CAGR
✓EBITDA margin holds above 30%31.9%
✗Free cash flow remains positive-₹1 Cr
✓Debt / EBITDA stays below 2x0.1x
✓ROCE stays above 47%49.7%